
Cell-selective siRNA
An address for the cell. An instruction for the gene.
The cell driving disease
a glycan its receptor recognises
Turn this gene down
an siRNA matched to its transcript
Every other cell
where the same gene is doing necessary work
Swap the instruction for a new disease. Swap the address for a new cell type.
Reduce disease-driving proteins at their source, opening access to targets long considered undruggable.
Target the cells driving disease while limiting effects on healthy cells.
Systematic decoding of glycans.
AI+MD proteome screening, paired with synthesis and experimental validation.
The vast combinatorial glycan chemical space
+400 protein families screened, candidates ranked for selectivity
Synthesis, structural analytics, binding, cell and in vivo studies
Ligands targeting immune cells, kidney, CNS, lungs and more.
Chronic inflammatory and age-related disease
Shared mechanisms. Multiple diseases.
Metabolic and liver
Inflammation that never resolves
Fibrotic organ disease
Repair that never switches off
Cardiorenal and vascular
Damage that accumulates
Neuro- and immune-mediated
Maintenance turned to harm
Targeting shared mechanisms across inflammatory and age-related conditions.

















